news
inquiry
Contact Us for business opportunity
Recruitment information
Japanese
English
HOME
vision
vision
Introducing the vision of SymBio
CEO message
SymBio in 2 minutes
Corporate culture
Charter of Corporate Conduct
Books
business model
business model
The following is an introduction to the business model of SymBio.
Business domain and profit model
Proprietary drug discovery business
Global business
Joint research with academia
Key person interview
pipeline
pipeline
SymBio introduces the pipeline of pharmaceuticals.
Pipeline overview
SyB V-1901
SyB L-0501
SyB L-1101/C-1101
IR information
IR information
Toward a patient-centered, supportive relationship among scientists, doctors, government, and shareholders.
Latest IR information
IR news
CEO message
financial highlights
IR library
Analyst
report
video library
IR Calendar
General Meeting of Shareholders Information
Basic stock information
Electronic public notice
About SymBio
About SymBio
Company Information of SymBio Pharmaceuticals
Company Profile
Origin of company name
History
Officer introduction
Organization chart
Corporate
governance
compliance
about
on transparency
Information disclosure
SDGs initiatives
news
inquiry
Contact Us for business opportunity
Recruitment information
Japanese
English
TOP
vision
CEO message
Fuminori Yoshida remarks
Fuminori Yoshida remarks
It all started with a will
dreams come true
Greetings from the listing
Dream of SymBio pharmaceuticals
Second founding
CEO talks
Regarding entry into delisting grace period
- CEO message
Video release of interim financial results briefing
- CEO message